Regulatory control of freeze-dried products: Importance and evaluation of residual moisture

Freeze-Drying/Lyophilization of Bharmaceutical and Biological Products

Volumn , Issue , 2004, Pages 349-384

  May, Joan C ^a  

^a Center for Biologics Evaluation and Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956415313     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (58)

1. EW Flosdorf. Freeze-Drying. New York: Reinhold, 1949.
2. EB Seligmann, Jr., JF Farber. Freeze-drying and residual moisture. Cryobiology 8:138-144, 1971.
3. MJ Pikal. Freeze-drying of proteins, Part I: Process Design. BioPharm 3:18-27, 1990.
4. MJ Pikal. Freeze-drying of proteins, Part II: Formulation selection. BioPharm 4:26-30, 1990.
5. LR Rey. Basic aspects and future trends in the freeze-drying of pharmaceuticals. Developments in Biological Standardization. In: Int. Assoc. Biol. Stand, ed. Basel: Karger, 1992, pp 3-8.
6. SL Nail, W Johnson. Methodology for in-process determination of residual water in freeze-dried products. In: Developments in Biological Standards, Int. Assoc. Biol. Stand, ed. Vol. 74. Basel: Karger, 1992, pp 137-151.
7. ML Roy, MJ Pikal. Process control in freeze-drying: determination of the end point of sublimation drying by an electronic moisture sensor. J Parent Sci Technol 43(2):60-66, 1989.
8. D Greiff. Protein structure and freeze-drying: the effects of residual moisture and gases. Cryobiology 8:145-152, 1971.
9. T Nei, T Araki, H Souzu. Studies of the effect of drying conditions on residual moisture content and cell viability in the freeze-drying of microorganisms. Cryobiology 2:68-73, 1965.
10. T. Nei, H Souzu, T Araki. Effect of residual moisture content on the survival of freeze-dried bacteria during storage under various conditions. Cryobiology 2:276-279, 1966.
11. D Greiff. Stabilities of suspensions of influenza virus dried by sublimation of ice in vacuo to different contents of residual moisture and sealed under different gases. Appl Microbiol 20:935-938, 1970.
12. JD Sparkes, P Fenje. The effect of residual moisture in lyophilized smallpox vaccine on its stability at different temperatures. Bull WHO 46:729-734, 1972.
13. Code of Federal Regulations. Test for residual moisture, 21CFR610.13(a). Washington, DC: U.S. Government Printing Office 1996:56-57, 1996.
14. JC May, RM Wheeler, N Etz, A Del Grosso. Measurement of final container residual moisture in freeze-dried biological products. Dev Boil Stand 74:153-164, 1992.
15. Code of Federal Regulations. Test for Residual Moisture, 21CFR610.13(a). Washington, DC: U.S. Government Printing Office 1988:52, 1988.
16. Code of Federal Regulations. Equivalent methods and processes, 21CFR610.9. Washington, DC: U.S. Government Printing Office 1988:45, 1988.
17. JC May, E Grim, RM Wheeler, J West. Determination of residual moisture in freeze-dried vial vaccines: Karl Fischer, gravimetric and thermogravimetric methodologies. J Biol Stand 10:249-259, 1982.
18. RN Pitombo, C Spring, RF Passos, M Tonato, M Vitolo. Effect of moisture content on the invertase activity of freeze-dried S. cerrevisiae. Cryobiology 31:383-392, 1994.
19. AW Ford, PJ Dawson. Effect of type of container; storage temperature and humidity on the biological activity of freeze-dried alkaline phosphatase. Biologicals 22:191-197, 1994.
20. LN Bell, MJ Hageman, LM Muraoka. Thermally induced denaturation of lyophilized bovine somatotropin and lysozyme as impacted by moisture and excipients. J Pharm Sci 84:707-712, 1995.
21. BD Herman, BD Sinclair, N Milton, SL Nail. The effect of bulking agent on the solid-state stability of freeze-dried methylprednisolone sodium succinate. Pharm Res 11:1467-1473, 1994.
22. C Oliyai, JP Patel, L Carr, RT Borchardt. Chemical pathways of peptide degradation. VII. Solid state chemical instability of an aspartyl residue in a model hexapeptide. Pharm Res 11:901-908, 1994.
23. C Oliyai, JP Patel, L Carr, RT Borchardt. Solid state chemical instability of an asparaginyl residue in a model hexapeptide. J Pharm Sci Technol 48:167-173, 1994.
24. BS Chang, NL Fischer. Development of an efficient single-step freeze-drying cycle for protein formulations. Pharm Res 12:831-837, 1995.
25. GD Adams, LI Irons. Some implications of structural collapse during freeze- drying using Erwinia caratovora L-asparaginase as a model. J Chem Technol Biotechnol 58:71-76, 1993.
26. RA Baffi, RL Garnick. Quality control issues in the analysis of lyophilized proteins. Dev Biol Stand 74:181-184, 1992.
27. MC Lai, MJ Hageman, RL Schawen, RT Borchardt, BB Laird, EM Topp. Chemical stability of peptides in polymers. 2. Discriminating between solvent and plasticizing effects of water on peptide deamidation in poly (vinylpyrro- lidone), J Pharm Sci 88:1081-1089, 1999.
28. MJ Pikal, RM Dellerman, ML Roy, RM Riggin. The effects of formulation variables on the stability of freeze-dried human growth hormone. Pharm Res 8:427-436, 1991.
29. AI Skrabanja, AL de Meere, RA de Ruiter, PJ van den Oetelaar. Lyophilization of biotechnology products. J Pharm Sci Technol 48:311-317, 1994.
30. M Mattern, G Winter, U Kohnert, G Lee. Formulation of proteins in vacuum- dried glasses. II. Process and storage stability in sugar-free amino acid system. Pharm Dev Technol 4:199-208, 1999.
31. M Katakam, KA Banga. Aggregation of proteins and its prevention by carbohydrate excipients: albumins and gamma-globulin. J Pharm Pharmacol 47:103-107, 1995.
32. LN Bell, MJ Hageman, JM Bauer. Impact of moisture on thermally induced denaturation and decomposition of lyophilized bovine somatotropin. Biopolymers 35:201-209, 1995.
33. C Hekman, S Park, WY Ten, NA Guzman, T Rossi. Degradation of lyophilized and reconstituted Macroscint. J Pharm Biomed Anal 13:1249-1261, 1995.
34. SJ Prestrelski, KA Pikal, T Arakawa. Optimization of lyophilization conditions for recombinant human interleukin-2 by dried-state conformational analysis using Fourier-transform infrared spectroscopy. Pharm Res 12:1250-1259, 1995.
35. MJ Pikal, K Dellerman, ML Roy. Formulation and stability of freeze-dried proteins: effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone. Dev Biol Stand 74:22-38, 1992.
36. SJ Prestrelski, T Arakawa, JF Carpenter. Separation of freezing- and drying- induced denaturation of lyophilized proteins using stress-specific stabilization. Arch Biochem Biophys 303:465-473, 1993.
37. A Dong, SJ Prestrelski, SD Allison, JF Carpenter. Infrared spectroscopic studies of lyophilization- and temperature-induced protein aggregation. J Pharm Sci 84:415-424, 1995.
38. B Lueckel, B Helk, D Bodmer, H Leuenberger. Effects of formulation and process variables on the aggregation of freeze-dried interleuking-6 (IL-6) after lyophilization and on storage. Pharm Dev Technol 3:337-346, 1998.
39. JM Sarciaux, S Mansour, MJ Hageman, SL Nail. Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-dryine. J Pharm Sci 88:1354-1361, 1999.
40. ED Breen, JG Curley, DE Overeashier, CC Hsu, SJ Shire. Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation. Pharm Res 18:1345-1353, 2001.
41. MJ Pikal S Shah. Moisture transfer from stopper to product and resulting stability implications. Dev Biol Stand 74:165-177, 1992.
42. B Crist. Time-dependence of pressure in lyophilization vials. J Pharm Sci Technol 48:189-196, 1994.
43. MJ Pikal, S Shah. Intravial distribution of moisture during the secondary drying stage of freeze drying. PDA J Pharm Sci Technol 51:17-24, 1997.
44. JC May, RM Wheeler, E Grim. The gravimetric method for the determination of residual moisture in freeze-dried biological products. Cryobiology 26: 277-284, 1990.
45. E Scholz. Karl Fischer Titration: Determination of Water Chemical Laboratory Practice. Berlin: Springer-Verlag, 1984.
46. United States Pharmacopeia/National Formulary (USP 23/NF 18) 1995. Water Determination. Rockville, MD: U.S. Pharmacopeial Convention, Inc., pp 1840-1842.
47. JC May, AV Del Grosso, RM Wheeler, N Etz. TG/MS capillary interface: applications to determination of residual moisture in BCG vaccine and other freeze-dried biological products. J Thermal Anal 49:929-936, 1997.
48. U.S. Pharmacopeia/National Formulary (USP 23/NF 18) 1995. Thermal Analysis. Rockville, MD: U.S. Pharmacopeial Convention, Inc., 1995, pp 1837-1838.
49. JC May, A Del Grosso, R. Wheeler. TG/MS interface: applications to the determination of moisture in polysaccharides and freeze-dried biological products. Thermochim Acta 115:289-295, 1987.
50. JC May, RM Wheeler, A Del Grosso. Compositional analysis of drugs and injectable biological products by thermogravimetry. In: AS'l’M Special Technical Publication 997. Philadelphia: American Society for Testing and Materials, 1988, pp 48-56.
51. CR Reimer, SJ Smith, TW Wells. The U.S. National Reference Preparation for Alpha-Fetoprotein in Mid-Pregnancy Maternal Serum. Clin Chem 28:709-716, 1982.
52. JC May, RM Wheeler, E Grim. The determination of residual moisture in several freeze-dried vaccines and a honey bee venom allergenic extract by TG/MS. J Thermal Anal 31:643-651, 1986.
53. L Rev. Personal communication.
54. LC Robinson. A gas chromatographic method of measuring residual water in freeze-dried smallpox vaccine. Bull WHO 47:7-11, 1972.
55. JE Jewell, R Workman, LD Zelenznick. Moisture analysis of lyophilized allergenic extracts. Dev Biol Stand 36:182-189, 1977.
56. L Kassai, K Sikos. Determination of moisture content of freeze-dried products by tritium isotope. Ann Immunol Hung 17:259-264, 1973.
57. IR Last, KA Prebble. Suitability of near-infrared methods for the determination of moisture in a freeze-dried injection product containing different amounts of the active ingredient. J Pharm Biomed Anal 2:1071-1076, 1993.
58. TP Lin, CC Hsu. Determination of residual moisture in lyophilized protein pharmaceuticals using a rapid and non-invasive method: near infrared spectroscopy. PDA J Pharm Sci Technol 56:196-205, 2002.